We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 88 results
  1. Investigation of cardioprotective effect of lercanidipine on doxorubicin-induced cardiotoxicity

    Although doxorubicin (DOX) is an effective anti-neoplastic drug for many types of cancer, particularly dose-related cardiotoxicity limits the use of...

    Nasif Fatih Karakuyu, Mehtap Savran, ... Yalcin Erzurumlu in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 07 June 2023
  2. Lercanidipine alleviates doxorubicin-induced lung injury by regulating PERK/CHOP and Bax/Bcl 2/Cyt c pathways

    Doxorubicin (DOX), which is used to treat various cancers and hematological malignancies, has limited therapeutic application due to its toxicity in...

    Muhammet Yusuf Tepebaşı, Jale Selli, ... Esma Selçuk in Histochemistry and Cell Biology
    Article 06 September 2023
  3. Exploratory Study on Lercanidipine Hydrochloride Polymorphism: pH-Dependent Solubility Behavior and Simulation of its Impact on Pharmacokinetics

    This work describes an exploratory experimental and in silico study of the influence of polymorphism, particle size, and physiology on the...

    Ilia Alekseevich Repin, Raimar Loebenberg, ... Gabriel L. B. de Araujo in AAPS PharmSciTech
    Article 21 January 2021
  4. Nasal Mucoadhesive Microspheres of Lercanidipine with Improved Systemic Bioavailability and Antihypertensive Activity

    Purpose

    The current study entails the design, development, and optimization of nasal mucoadhesive microspheres of lercanidipine with improved systemic...

    Sarwar Beg, Mahfoozur Rahman, ... Bhupinder Singh in Journal of Pharmaceutical Innovation
    Article 24 March 2020
  5. A Design-assisted Spectrofluorometric Method Utilizing a One-pot Fluorescent Probe for the Quantitation of some Calcium Channel Blockers

    Based on their reaction with highly fluorescent carbon quantum dots (CQDts), a precise and reliable spectrofluorometric approach was developed for...

    Aya Roshdy, Randa Abdel Salam, ... Heba Elmansi in Journal of Fluorescence
    Article Open access 08 December 2022
  6. A novel transdermal nanoethosomal gel of lercanidipine HCl for treatment of hypertension: optimization using Box-Benkhen design, in vitro and in vivo characterization

    Poor bioavailability of drugs via oral route is the greatest challenge facing drug formulation. To overcome this obstacle, transdermal route was...

    Heba F. Salem, Shahira F. El-Menshawe, ... Yasmine K. Rabea in Drug Delivery and Translational Research
    Article 17 October 2019
  7. Paraptosis: a non-classical paradigm of cell death for cancer therapy

    Due to the sustained proliferative potential of cancer cells, inducing cell death is a potential strategy for cancer therapy. Paraptosis is a mode of...

    Chun-cao Xu, Yi-fan Lin, ... **-jian Lu in Acta Pharmacologica Sinica
    Article 15 September 2023
  8. Determination of drug-related problems according to PAIR criteria in dialysis patients: a cross-sectional study in tertiary care hospital

    Background

    Dialysis patients are at high risk for drug-related problems (DRPs), which have significant consequences for their morbidity, mortality,...

    Aysel Pehlivanli, Sayeste Akkan Eren, ... A. Tanju Ozcelikay in BMC Pharmacology and Toxicology
    Article Open access 18 April 2024
  9. Correction to: A novel transdermal nanoethosomal gel of lercanidipine HCl for treatment of hypertension: optimization using Box-Benkhen design, in vitro and in vivo characterization

    In the original article, there are errors in Tables 2 and 6. Following are the corrected tables.

    Heba F. Salem, Shahira F. El-Menshawe, ... Yasmine K. Rabea in Drug Delivery and Translational Research
    Article 12 November 2019
  10. Drug Repurposing in Gastric Cancer: Current Status and Future Perspectives

    Gastric cancer remains an important contributor to the global cancer burden ranking the 5th most common and the 4th most deadly cancer, according to...
    Marina Leite, Raquel Seruca, Jorge M. Gonçalves in Hereditary Gastric and Breast Cancer Syndrome
    Chapter 2023
  11. Polypharmacology in Clinical Applications: Renal Polypharmacology

    The urinary system, also known as the renal system or urinary tract, consists of the kidneys ,...
    Zhiguo Wang, Baofeng Yang in Polypharmacology
    Chapter 2022
  12. Studies on the mechanisms of action of MR33317

    MR33317 was synthesized as an acetylcholinesterase-inhibitor and an agonist at brain 5-HT 4 -receptors. MR33317 might be used to treat Morbus...

    Joachim Neumann, C. Hesse, ... U. Gergs in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 10 June 2024
  13. Polygenic scores for cardiovascular risk factors improve estimation of clinical outcomes in CCB treatment compared to pharmacogenetic variants alone

    Pharmacogenetic variants are associated with clinical outcomes during Calcium Channel Blocker (CCB) treatment, yet whether the effects are modified...

    Deniz Türkmen, Jack Bowden, ... Luke C. Pilling in The Pharmacogenomics Journal
    Article Open access 17 April 2024
  14. Harmonization of summaries of product characteristics (SmPCs) of drugs with the same active ingredients: an evaluation of SmPCs of the most frequently prescribed active substances

    Purpose

    In aut-idem or generic substitution, discrepancies between summaries of product characteristics (SmPCs) referring to the same active substance...

    Maximilian Gahr, Bernhard J. Connemann, ... Almuth Wolf in European Journal of Clinical Pharmacology
    Article Open access 27 October 2021
  15. Recent Applications of Quantum Dots in Pharmaceutical Analysis

    Nanotechnology has emerged as one of the most potential areas for pharmaceutical analysis. The need for nanomaterials in pharmaceutical analysis is...

    Fathalla Belal, Mokhtar Mabrouk, ... Aya Barseem in Journal of Fluorescence
    Article 24 May 2023
  16. Duplicate prescriptions in the emergency department: a retrospective cohort study

    Purpose

    To determine the nature and frequency of duplicate prescriptions (DPs) in the emergency department (ED) by utilization of a novel...

    Johannes Heck, Benjamin Krichevsky, ... Olaf Krause in European Journal of Clinical Pharmacology
    Article Open access 08 December 2022
  17. Ifosfamide-induced encephalopathy: the EEG with frontal intermittent delta activity, and rapid resolution with methylene blue: A case report

    Background

    Encephalopathy is an established side effect of the chemotherapeutic agent, ifosfamide, occurring in 10–30% of cases. The EEG commonly...

    Juliette E. Hamilton, Michael Alexander, Fergal C. Kelleher in Clinical Sarcoma Research
    Article Open access 28 November 2020
  18. The combined effects of telmisartan and ramipril on hypertension and cardiovascular injury

    Purpose

    More than half of hypertensive patients receive combination therapy with two or more drugs. For combination therapy with antihypertensive...

    Do-Hyung Lee, Min-Tae Kim, ... Chang-Seon Myung in Journal of Pharmaceutical Investigation
    Article 18 March 2022
  19. Response Surface Designs and Their Applications in Pharmaceutical Development

    The response surface methodology (RSM) requires high-resolution designs which are particularly useful for the optimization purpose. It is now...
    Chapter 2021
Did you find what you were looking for? Share feedback.